Novartis Egypt supports COP27, showcases commitment to water, energy saving
With the participation of the Ministry of Environment represented by Ahmed Hafez,…
Novartis partners with Baheya, reiterates commitment to breast cancer patients in Egypt
Novartis solidifies support for breast cancer patients with the Waraha Kessa campaign,…
Novartis Egypt and HAYAH Patient Advocacy Group Celebrate World CML Day
Renowned hematologist, Dr Mervat Mattar, Professor of Hematology at Cairo University said,…
Novartis, Sandoz demonstrate pivotal impact of public-private partnerships to strengthen healthcare sustainability
Egyptian healthcare system achieves revolutionary progress, we are privileged to support this…
Novartis launches novel treatment for adult patients with SPMS in Egypt
The event took place in cooperation with the MS Chapter of the…
Novartis reveals new hope with overall survival benefit for HR+/HER2- advanced breast cancer patients
“Breast cancer is the most common form of cancer among Egyptian women…
Breakthrough treatment from Novartis sparks new hope for HR+/HER2- advanced breast cancer patients
“Breast cancer is the most common form of cancer among Egyptian women,…
Novartis Egypt launches campaign to address critical risk of high blood cholesterol
46% of deaths in country caused by cardiovascular disease
Novartis remains committed to supporting Egypt’s COVID-19 fight
Pharmaceutical company announces formation of $40m global Novartis COVID-19 Response Fund
Novartis launches ‘Oncology On Air’ campaign for raising awareness on breast cancer
Breast cancer responsible for about 15% of deaths of tumours